rs140666848

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001364905.1(LRBA):​c.2444A>G​(p.Asn815Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00235 in 1,563,408 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. N815N) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0021 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 7 hom. )

Consequence

LRBA
NM_001364905.1 missense

Scores

3
9
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:8

Conservation

PhyloP100: 7.87

Publications

9 publications found
Variant links:
Genes affected
LRBA (HGNC:1742): (LPS responsive beige-like anchor protein) The protein encoded by this gene is a member of the WDL-BEACH-WD (WBW) gene family. Its expression is induced in B cells and macrophages by bacterial lipopolysaccharides (LPS). The encoded protein associates with protein kinase A and may be involved in leading intracellular vesicles to activated receptor complexes, which aids in the secretion and/or membrane deposition of immune effector molecules. Defects in this gene are associated with the disorder common variable immunodeficiency-8 with autoimmunity. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
LRBA Gene-Disease associations (from GenCC):
  • combined immunodeficiency due to LRBA deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.017331034).
BP6
Variant 4-150870530-T-C is Benign according to our data. Variant chr4-150870530-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 218542.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00213 (324/152264) while in subpopulation NFE AF = 0.00385 (262/68010). AF 95% confidence interval is 0.00347. There are 1 homozygotes in GnomAd4. There are 148 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRBANM_001364905.1 linkc.2444A>G p.Asn815Ser missense_variant Exon 20 of 57 ENST00000651943.2 NP_001351834.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRBAENST00000651943.2 linkc.2444A>G p.Asn815Ser missense_variant Exon 20 of 57 NM_001364905.1 ENSP00000498582.2

Frequencies

GnomAD3 genomes
AF:
0.00214
AC:
325
AN:
152150
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000434
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000721
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00254
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00387
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00221
AC:
553
AN:
250170
AF XY:
0.00222
show subpopulations
Gnomad AFR exome
AF:
0.000493
Gnomad AMR exome
AF:
0.000319
Gnomad ASJ exome
AF:
0.000993
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00256
Gnomad NFE exome
AF:
0.00379
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.00237
AC:
3344
AN:
1411144
Hom.:
7
Cov.:
25
AF XY:
0.00227
AC XY:
1601
AN XY:
705364
show subpopulations
African (AFR)
AF:
0.000215
AC:
7
AN:
32494
American (AMR)
AF:
0.000381
AC:
17
AN:
44610
Ashkenazi Jewish (ASJ)
AF:
0.000659
AC:
17
AN:
25780
East Asian (EAS)
AF:
0.0000255
AC:
1
AN:
39292
South Asian (SAS)
AF:
0.000892
AC:
76
AN:
85202
European-Finnish (FIN)
AF:
0.00247
AC:
130
AN:
52568
Middle Eastern (MID)
AF:
0.00476
AC:
27
AN:
5670
European-Non Finnish (NFE)
AF:
0.00277
AC:
2955
AN:
1066842
Other (OTH)
AF:
0.00194
AC:
114
AN:
58686
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
141
282
422
563
704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00213
AC:
324
AN:
152264
Hom.:
1
Cov.:
32
AF XY:
0.00199
AC XY:
148
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.000433
AC:
18
AN:
41556
American (AMR)
AF:
0.000720
AC:
11
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.00254
AC:
27
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00385
AC:
262
AN:
68010
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
15
30
45
60
75
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00268
Hom.:
3
Bravo
AF:
0.00178
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00419
AC:
36
ExAC
AF:
0.00252
AC:
306
Asia WGS
AF:
0.000578
AC:
2
AN:
3472

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Apr 21, 2021
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified in two consanguinious LRBA-deficient siblings in the published literature with primary immunodeficiency who also had a homozygous frameshift variant in the LRBA gene that was believed to be the cause of their symptoms (Seidel et al., 2015); Identified in multiple affected relatives in a large pedigree in the published literature with Hirschsprung disease in addition to a relative with functional constipation and multiple unaffected relatives (Sribudiani et al., 2018); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 25539626, 29601828) -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LRBA: BS2 -

not specified Benign:3
Dec 02, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 10, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 20, 2019
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hirschsprung disease, susceptibility to, 1 Uncertain:1
Nov 18, 2016
Clinical Genetics, Erasmus University Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Combined immunodeficiency due to LRBA deficiency Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

LRBA-related disorder Benign:1
May 19, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.58
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.33
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.32
.;T;.
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.93
D;D;D
M_CAP
Benign
0.043
D
MetaRNN
Benign
0.017
T;T;T
MetaSVM
Benign
-0.45
T
MutationAssessor
Uncertain
2.7
M;M;.
PhyloP100
7.9
PrimateAI
Uncertain
0.68
T
PROVEAN
Pathogenic
-4.4
D;D;D
REVEL
Uncertain
0.30
Sift
Uncertain
0.0030
D;D;D
Sift4G
Uncertain
0.0030
D;D;D
Polyphen
0.98
D;P;.
Vest4
0.80
MVP
0.63
MPC
0.50
ClinPred
0.038
T
GERP RS
4.5
Varity_R
0.43
gMVP
0.64
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140666848; hg19: chr4-151791682; COSMIC: COSV105254217; API